Chromadex Corp (NASDAQ: CDXC) is 44.96% higher on its value in year-to-date trading and has touched a low of $1.57 and a high of $9.18 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CDXC stock was last observed hovering at around $8.55 in the last trading session, with the day’s loss setting it -0.86%.
Currently trading at $7.69, the stock is 31.31% and 34.69% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.35 million and changing -10.06% at the moment leaves the stock 74.03% off its SMA200. CDXC registered 363.25% gain for a year compared to 6-month gain of 134.45%.
The stock witnessed a 39.69% loss in the last 1 month and extending the period to 3 months gives it a 1.72%, and is 41.36% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.34% over the week and 6.77% over the month.
Chromadex Corp (CDXC) has around 104 employees, a market worth around $597.90M and $99.60M in sales. Current P/E ratio is 73.03 and Fwd P/E is 43.53. Profit margin for the company is 8.58%. Distance from 52-week low is 389.81% and -16.23% from its 52-week high. The company has generated returns on investments over the last 12 months (17.91%).
The EPS is expected to grow by 6.06% this year
The shares outstanding are 77.33M, and float is at 49.23M with Short Float at 4.46%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 3.39 million shares valued at $9.24 million. The investor’s holdings represent 4.5014 of the CDXC Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 3.12 million shares valued at $8.51 million to account for 4.1422 of the shares outstanding. The other top investors are TIETON CAPITAL MANAGEMENT, LLC which holds 2.97 million shares representing 3.9281 and valued at over $8.1 million, while ICONIQ CAPITAL, LLC holds 1.7157 of the shares totaling 1.3 million with a market value of $3.54 million.
Chromadex Corp (CDXC) Insider Activity
The most recent transaction is an insider sale by Jaksch Frank L Jr, the company’s Director. SEC filings show that Jaksch Frank L Jr sold 37,161 shares of the company’s common stock on Dec 13 ’24 at a price of $6.19 per share for a total of $0.23 million. Following the sale, the insider now owns 0.24 million shares.
Still, SEC filings show that on Nov 22 ’24, Pamir Ozan (Chief Financial Officer) acquired 2,907 shares at an average price of $7.36 for $21397.0. The insider now directly holds 2,907 shares of Chromadex Corp (CDXC).
